Acetato de deshidronandrolona CAS:2590-41-2

Dehydronandrolon acetate is a key intermediate for the synthesis of (faslodex) y , while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, ganancias musculares duraderas. Esto se debe a la vida media relativamente larga del fármaco.. Los usuarios informan efectos secundarios leves, siendo el mayor efecto secundario la retención de agua.

Applications:
Dehydronandrolon acetate is an effective compound that produces quality, ganancias musculares duraderas. Esto se debe a la vida media relativamente larga del fármaco. (alrededor 8 días). Los usuarios informan efectos secundarios leves, siendo el mayor efecto secundario la retención de agua.